Intestinal and hepatic FXR activity is also paramount for the regulation of BA synthesis, and suppression of this signalling is thought to contribute to the elevated BA synthesis and altered enterohepatic circulation of BAs in individuals with MASLD [33]. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.